GLP-1 medications and related compounds

Tirzepatide

An FDA-approved prescription active ingredient with dual GIP and GLP-1 receptor agonist activity in approved products.

ZepboundMounjaroGIP/GLP-1 receptor agonist

Concise answer

What is Tirzepatide?

Tirzepatide is the active ingredient in FDA-approved prescription products. It has strong human trial evidence for approved uses, while unapproved or compounded versions are not FDA-approved.

Definition

What It Is

Tirzepatide is a dual incretin receptor agonist active ingredient used in FDA-approved prescription products. PeptideWars treats it as a regulated medication, not a research-only peptide.

Status

Legal and Regulatory Notes

FDA: FDA-approved in specific prescription products and indications. Use depends on product labeling, medical history, and clinician oversight.
Research: Large randomized human trials support approved uses. Evidence for unapproved versions or marketing claims should not be assumed.
Sport: Not categorized here as a research peptide for anti-doping purposes; athletes should verify rules for all medications.

Research map

How Tirzepatide Is Being Studied

Weight management under approved product labelingType 2 diabetes and glycemic outcomes under approved labelingSleep apnea indication in adults with obesity under product labelingSafety and regulatory concerns around unapproved GLP-1 products

People

Human Research

SURMOUNT-1 and other trials provide high-quality human evidence in studied populations, with gastrointestinal adverse events commonly reported.

Models

Animal and Cell Research

Preclinical research is part of drug development, but human trials and FDA labeling drive this page's evidence grade.

Safety

Known Risks and Side Effects

Gastrointestinal adverse effects are common in trial and label discussions
Label warnings, contraindications, and drug interactions need clinician review
FDA has raised concerns about unapproved GLP-1 products, including dosing errors and adverse events
Not interchangeable with research-use products sold online

Compliance

Interpretation Guardrails

FDA-approved tirzepatide products have official labeling; compounded or unapproved products do not have FDA approval.
Avoid websites that imply research-use or compounded products are the same as approved medication.
Talk to a licensed clinician for medication decisions.

Internal links

Related Battles and Profiles

Battle Tirzepatide vs Semaglutide Two FDA-approved incretin active ingredients compared on evidence, approved-product status, safety, and regulatory cautions. Profile Semaglutide An FDA-approved GLP-1 receptor agonist active ingredient used in prescription products for label-defined indications. Profile Tesamorelin An FDA-approved GHRH analog product for a specific HIV-associated lipodystrophy indication. Guide Weight Management Peptides Separate FDA-approved incretin medications from research peptides and cosmetic weight-loss hype. Guide GLP-1 Medications and Related Compounds Approved medicines, compounded versions, counterfeit risk, and research compounds separated clearly.

FAQ

Common Questions

Is tirzepatide FDA-approved?

Specific tirzepatide products are FDA-approved for specific indications. Product labels define the approved uses and safety information.

Is compounded tirzepatide FDA-approved?

No. FDA states compounded drugs are not FDA-approved and has published concerns about unapproved GLP-1 drugs.

Is tirzepatide stronger than semaglutide?

Trials suggest strong weight-management effects for tirzepatide, but individual treatment choice depends on labeling, risks, access, medical history, and clinician judgment.

Sources

Citations and Official References

Editorial Review

Written by the PeptideWars Editorial Team. Medical reviewer placeholder: licensed clinician review should be completed before production launch. Last updated May 6, 2026.